(Q44961282)

7 December 2017

title

Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours (English)

1 reference

7 December 2017

1

1 reference

7 December 2017

2

1 reference

7 December 2017

Zsolt Garami

3

1 reference

7 December 2017

Ashraf El-Mitwalli

series ordinal

4

1 reference

7 December 2017

Lewis B Morgenstern

series ordinal

5

1 reference

7 December 2017

James C Grotta

series ordinal

6

1 reference

7 December 2017

publication date

22 February 2005

1 reference

7 December 2017

published in

Cerebrovascular Diseases

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

260-266

1 reference

Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?

7 December 2017

cites work

1 reference

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

21 January 2018

1 reference

Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status

21 January 2018

1 reference

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

21 January 2018

1 reference

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study

21 January 2018

1 reference

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

A predictive risk model for outcomes of ischemic stroke.

21 January 2018

1 reference

Predicting functional outcome and survival after acute ischemic stroke

21 January 2018

1 reference

Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.

21 January 2018

1 reference

Yield of transcranial Doppler in acute cerebral ischemia

21 January 2018

1 reference

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy

21 January 2018

1 reference

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

21 January 2018

1 reference

Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke

21 January 2018

1 reference

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

21 January 2018

1 reference

Thrombolytic therapy with streptokinase in acute ischemic stroke

21 January 2018

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism

21 January 2018

1 reference

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies

21 January 2018

1 reference

Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial

21 January 2018

1 reference

Is the benefit of early recanalization sustained at 3 months? A prospective cohort study

21 January 2018

1 reference

Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra

21 January 2018

1 reference

Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia

21 January 2018

1 reference

Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke

21 January 2018

1 reference

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084090

1 reference

7 December 2017

1 reference